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I. INTRODUCTION
Maria Silverwood' was excited when, on her twenty-fifth
birthday, she was hired as a sales manager trainee for a Seattle
company that manufactured computer graphic equipment. As a single
mother, Maria needed a stable, secure job with potential for promotion.
When Maria went for her mandatory new employee physical examina-
tion, she filled out a routine medical history form, on which she noted
that her mother had died of Huntington's disease. Maria was shocked
when she later found out she was ineligible for company-sponsored
disability insurance because of the information she included in her
medical history.
Nonetheless, Maria expected to move quickly up the ranks at her
new company. She consistently received "excellent" ratings in
performance reviews, and she was named "employee of the year"
during her second and third years with the company. Maria's
immediate supervisor repeatedly told her that she definitely was
management material.
Four years after being hired, however, Maria was still classified as
a trainee and paid at trainee's wages. Since the salary raises she had
expected never materialized, Maria, as a single mother, found it
increasingly difficult to make ends meet. What Maria suspected, but
could not prove, was that she was denied promotion on the basis of her
genetic history, just as she had been denied disability insurance. The
truth was that company managers knew of Maria's genetic history, as
reported when she was hired. They had not promoted Maria into a
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1. Maria Silverwood is a fictional character. Any resemblance between Maria and any
person, living or deceased, is purely coincidental. For a "true life" example of how the issues
related to genetic testing can have a dramatic, personal impact, see Catherine Sack, Washington
Diarist, Tropic of Cancer, THE NEW REPUBLIC, June 2, 1997, at 46.
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management position because of the possibility that she carried the
Huntington's gene.
What Maria had experienced was discrimination on the basis of
her unique and personal genetic information. Huntington's disease is
an inherited disease.2 Since Maria's mother died from the disease, the
disability insurer and her employer both made the assumption that
Maria was at risk of developing the same affliction. Consequently, she
was denied both disability insurance and a promotion that was
rightfully hers. This is discrimination based on information on a
person's genetic make-up, and is known as genetic discrimination.3
In addition to being subjected to discrimination, Maria experi-
enced an invasion of her privacy. When she completed the medical
history form as part of her new employee physical, she assumed that
the family history information she included would remain confidential.
Similarly, when Maria signed a form authorizing her company's health
insurance carrier to access her medical records, she thought that any
information accessed would be used for claims verification and
payment purposes only. Unfortunately, the health insurance carrier
did not limit its disclosure of the information to claims verification.
The health insurer redisclosed Maria's genetic information both to the
disability insurance carrier and to her employer without Maria's
knowledge or permission.4 This unauthorized redisclosure of her
genetic information had unfortunate consequences for Maria, even
though she was in good health and the odds are only one in four that
2. Huntington's disease is a hereditary condition that causes a progressive deterioration of
brain cells. Symptoms usually do not develop until middle age. It is perhaps best known as the
disease that killed folk singer Woody Guthrie. The incidence of Huntington's disease in the
general population is approximately 1 in 10,000. However, the Huntington's gene is always
expressed, meaning that every individual who carries the gene will manifest symptoms of the
disease, in middle age. If one parent carries the Huntington's gene, as in Maria's case, the child
has a 25% chance of carrying the gene. See PETER H. RAVEN ET AL., BIOLOGY 268 (Times
Mirror/Mosby College Publishing 2d ed. 1989); Henry T. Greely, The Control of Genetic
Research: Involving the "Groups Between," 33 Hous. L. REV. 1397, 1425-26 (1997).
3. Genetic discrimination has been defined as "discrimination against an individual or
against members of that individual's family solely because of real or perceived differences from
the 'normal' genome in the genetic constitution of that individual." George P. Smith, Accessing
Genomic Information or Safeguarding Genetic Privacy, 9 J.L. & HEALTH 121, 124 (1995). Thus,
genetic discrimination occurs when an asymptomatic individual receives disparate treatment based
on information that is part of his genetic make-up. Id.
4. As used in this article, redisclosure of genetic information refers to secondary disclosure
for some purpose other than that originally anticipated. For example, medical record information
is typically disclosed to insurance carriers for the purpose of verifying that payment requests by
physicians match actual patient diagnosis and treatment. A secondary disclosure, or redisclosure,
occurs when an insurance carrier makes patient information available to others for some use
unrelated to payment verification.
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she will ever manifest the symptoms of Huntington's disease. Maria
Silverwood found out what can happen if genetic information is not
afforded special protection.
Current Washington state law is inadequate to protect people like
Maria, because genetic information needs special protection but
currently receives none. To prevent the Maria Silverwoods of
Washington from experiencing invasions of genetic privacy and
potential genetic discrimination, their genetic information must be
given special protection. Accordingly, Washington legislators must
adopt a Genetic Privacy Act that will provide the needed protection.
The next section of this Comment presents background informa-
tion concerning genetic information and genetic testing. Section III
then argues that privacy and autonomy are significant policy issues in
connection with genetic information. As a result, the decision to have
genetic testing performed should be an individual's choice, and genetic
testing should never be compelled. Section IV argues that the failure
to give genetic information special protection in the law has potentially
harmful consequences. Section V surveys current efforts to protect
genetic privacy, both by the federal government and states other than
Washington. Section V also analyzes the current state of medical
records privacy protection in Washington, and argues that the current
state law is inadequate to protect genetic privacy and to prevent genetic
discrimination. Finally, Section VI presents a substantive proposal for
a Genetic Privacy Act in Washington, which would protect individual
privacy, prohibit compelled testing, and prevent genetic discrimination.
This Comment concludes that under current state law Washington
citizens risk losing genetic privacy and experiencing genetic discrimina-
tion. Consequently, the legislature should enact a Genetic Privacy Act
to ensure both protection of genetic privacy and prevention of genetic
discrimination in Washington.
II. GENETIC INFORMATION AND GENETIC TESTING
Every cell of the human body carries genetic information.' The
information is encoded in DNA and organized in genes, which are the
basic unit of heredity.6 Each person's genes are unique,7 and they
carry a map of that person's biological past and future.' In addition,
5. See generally RAVEN ET AL., supra note 2, at 256-70 (1989).
6. Id. at 94.
7. See id. at 225.
8. See id. at 231-42.
1997]
Seattle University Law Review
genes are the vehicle by which characteristics are inherited from our
parents and passed on to our children.'
The essence of the personal nature of genetic information is
captured by the term "future diary."'0 A diary contains past informa-
tion that is very personal and private." By contrast, genetic informa-
tion can be described as a "probabilistic future diary," because it
carries predictive information about future health. 12  Thus, the
significance of genetic information arises both from its unique nature,
different in each person, and its predictive nature, in what it might tell
about each person's future. 3
Genetic information is an important class of health information
because a significant number of human disorders have a genetic
component. 4 Research scientists are currently attempting to develop
technology which will allow greater diagnosis, understanding, and
treatment of genetic disorders. 5  The Human Genome Project
(HGP),16 an international effort to build a complete map of the entire
human genome, leads the way in this research." The HGP is
expected to lead to improved understanding, treatment, prevention, and
eventually cures for many genetic disorders." This knowledge is also
expected to lead to the widespread availability of genetic testing in the
near future.'9
Genetic testing involves the direct testing of genetic make-up by
laboratory analyses of DNA, in order to determine the presence or
9. See id. at 257.





14. At least 5,000 human disorders are thought to have a genetic component, and new
genetic diseases are discovered at a rate of 150 per year. See Richard A. Bornstein, Genetic
Discrimination, Insurability and Legislation: A Closing of the Legal Loopholes, 4 J.L. & POL'Y 551,
557 n.28 (1996).
15. See Smith, supra note 3, at 126-27.
16. Alastair T. lies, The Human Genome Project: A Challenge to the Human Rights Frame-
work, 9 HARV. HUM. RTS. J. 27, 29 (1996).
17. Genome is the term used to describe the total genetic composition of an organism. In
human beings, the genome consists of 42 chromosomes. Genes, the basic units which carry
genetic information, are organized along the chromosomes. See RAVEN ET AL., supra note 2, at
256.
18. See Elizabeth J. Thomson, Ethical, Legal, and Social Implications of the Human Genome
Project, 3 DICK. J. ENVTL. L. & POL'Y 55 (1994). See also Smith, supra note 3, at 126 (stating
"The driving motive behind the Human Genome Initiative is ... the identification and
eradication of all genetically based disease.").
19. See Bornstein, supra note 14, at 558-62.
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absence of defective genes." Genetic testing supplements family
history information, which has been the traditional source of informa-
tion on genetic make-up.2 The widespread availability of genetic
testing may prove to be tremendously beneficial for some people. For
example, genetic testing is a useful tool for the early detection of some
diseases, which often increases the potential for successful treatment.22
In addition, the availability of genetic testing should facilitate a shift
toward preventive medicine since preventive measures may be available
in some cases where a genetic predispostion has been identified.23
Moreover, as technology advances, some diseases might be treatable on
a genetic level, ultimately preventing symptoms entirely.24
The advent of genetic testing, however, raises important policy
questions concerning the privacy and control of genetic information.
Legislative responses to these policy questions have not kept pace with
the recent rapid advances in the medical sciences.2" Maria Silver-
wood's situation underscores the need for legislative action to protect
individual privacy and control over genetic information. The
interrelated issues of a person's privacy and control of his or her
genetic information are discussed further in the next section.
III. PRIVACY AND AUTONOMY WITH RESPECT
TO GENETIC INFORMATION
Privacy and autonomy are overlapping concepts in the context of
genetic information.26 Privacy suggests limited access to a person, or
20. See id. at 551 n.2.
21. See id. at 558.
22. See Christopher P. Blake, Rev. of Selected 1995 Cal. Legis.: Insurance; Genetic Discrim-
ination, 27 PAC. L.J. 870, 872 (1996).
23. See generally Bornstein, supra note 14, at 569-72 n.3; Blake, supra note 22, at 872.
24. See Blake, supra note 22, at 872.
25. See Bornstein, supra note 14, at 555.
26. A general right to privacy is not guaranteed by the United States Constitution. Katz
v. United States, 389 U.S. 347, 350 (1967). However, the United States Supreme Court has
identified two types of privacy interests deserving of protection: (1) the right to be protected from
disclosure to the government of certain personal matters, and (2) the right to make certain
fundamental decisions without governmental interference. Whalen v. Roe, 429 U.S. 589, 599-600
(1977). Washington explicitly adopted Whalen v. Roe as being consistent with the privacy
protections contained in Article 1, section 7 of the Washington state constitution in Peninsula
Counseling Center v. Rahm, 105 Wash. 2d 929, 934-35, 71 P.2d 926, 928-29 (1986). Significantly,
the privacy interests recognized in Whalen and Peninsula Counseling provide privacy protection
only from the government. The privacy interests identified in Katz and adopted in Peninsula
Counseling do not provide protection from third party, nongovernmental disclosure of personal
information, or from nongovernmental interference with autonomous decisionmaking.
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freedom for that person from intrusion by others.27 Autonomy, on
the other hand, suggests that people should have the right to make
decisions about personal and intimate matters without interference or
intrusion by others.2' Together, these concepts underscore the
essential nature of an individual's ability "to make personal decisions
without interference." 29  These two interrelated issues are explored
further in the following subsections.
A. Privacy
Genetic privacy concerns an individual's right to control who can
gain access to his or her private health care information. A person has
a reasonable expectation that personal, sensitive information in medical
records will remain confidential and will not be revealed to third
parties without that person's consent.3" The privacy of health care
information traditionally has been protected by rules regarding
physician-patient confidentiality.31 In some states, the privacy of
health care information is also protected by statute.32 In Washington,
for example, the confidentiality of health care information is protected
by the Health Care Information Access and Disclosure Act.33
Despite such legal protections arising from both custom and
statutes, however, the privacy of genetic information as a class of
health care information is seriously at risk for several reasons. First,
patients typically are asked to authorize the release of medical
information to third parties, such as insurance companies, as a routine
part of the paperwork associated with a visit to a doctor's office. Maria
Silverwood signed this type of release when she received her new-
employee physical examination. Insurance companies make valid use
of this information, such as verification of diagnosis and treatment, in
order to authorize proper payment of claims. However, there is little
limitation on what insurance companies can do with this information
27. See Mark A. Rothstein, Preventing the Discovery of Plaintiff Genetic Profiles by
Defendants, 71 IND. L.J. 877, 894 (1996).
28. See id.
29. Bornstein, supra note 14, at 572.
30. See Rothstein, supra note 27, at 896. See also Lawrence 0. Gostin et al., Privacy and
Security of Health Information in the Emerging Health Care System, 5 HEALTh MATRIX 1, 2
(1995).
31. Confidentiality has been considered as one of the primary duties of a physician since
the Oath of Hippocrates was first conceived in the fifth century B.C. See Rothstein, supra note
27, at 896. See also Gostin et al., supra note 30, at 20-23.
32. See id. at 15.
33. See WASH. REV. CODE § 70.02 (1996).
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once they gain access to it.34  As Maria Silverwood ultimately
discovered, third parties may redisclose information without the
patient's knowledge or consent.
Second, personal information about individuals is a profitable
industry.3" There is a tremendous market for all kinds of personal
information, including medical information. 6 Thus, there is a strong
incentive for third parties, such as insurance companies, to make
personal information available to other users, without the knowledge
or consent of the individual to whom the information pertains.
37
Finally, given the explosion in the computer industry over the last
ten years, it is increasingly easy to collect and exchange information.
It is relatively easy to develop a detailed profile of many aspects of an
individual's health, including genetic information.38 Credit reporting
companies, employers, and insurance companies all have the potential
to search medical histories.39 As a result, mortgage, employment, and
insurance applications are potentially influenced by the applicant's
genetic information, without the applicant's knowledge that the
information is part of the decisionmaking process.4"
Currently, Washington citizens have no statutory or common law
recourse to address the unauthorized third-party redisclosure of genetic
information as an invasion of privacy. First, Washington courts do not
recognize an invasion of privacy as a common law tort cause of
action.4 In addition, the Uniform Health Care Information and
Disclosure Act provides for a cause of action only if health care
providers disclose information without consent.42 An equivalent cause
of action is not available to address nonconsensual redisclosure of
information by third parties, such as insurance carriers.43 Finally, the
34. See Gostin et al., supra note 30, at 16.
35. Some reports estimate that there are over 10,000 available lists which contain data about
individuals. In addition, the business of selling personal information was recently estimated as
a three billion dollar per year industry. See Judith Beth Prowda, Privacy and Security of Data,
64 FORDHAM L. REV. 738, 740 (1995).
36. See id. See also Michael Landau, Use of Genetic Testing by Employers and Insurance
Companies, 3 J. ENVTL. L. & POL'Y 105 (1994).
37. See Prowda, supra note 35, at 740.
38. Elaine Alma Draper, Social Issues of Genome Innovation and Intellectual Property, 7 RISK:
HEALTH, SAFETY & ENV'T 201, 205 (1996). See also Prowda, supra note 35, at 740.
39. Interestingly, videotape rental records currently have more privacy protection than
medical records. See Prowda, supra note 35, at 755.
40. Draper, supra note 38, at 205.
41. See Doe v. Group Health Cooperative of Puget Sound, Inc., 85 Wash. App. 213, 221,
932 P.2d 178, 181-82 (1997).
42. See WASH. REV. CODE § 70.02.030 (1996). See also discussion, infra, Part V.C.
43. See generally WASH. REV. CODE § 70.02 (1996).
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right to privacy guaranteed by Article 1, section 7 of the Washington
State Constitution applies to the disclosure of intimate information to
the government, but not to third parties." Consequently, specific
legislation is needed to ensure protection of genetic privacy in
Washington.
B. Autonomy
In contrast to privacy, genetic autonomy concerns each person's
ability to make the very personal decision of whether to undergo
genetic testing. This private decision must be made without interfer-
ence, intrusion, or coercion.4" In order to preserve individual autono-
my, genetic testing should be performed only for the primary benefit
of the person tested;46 genetic testing should never be compelled.47
The decision to undergo genetic testing can be a very difficult
choice to make.48 Certainly, some people will undergo genetic testing
out of a desire to know all they possibly can about their future health
status. However, others might be traumatized to learn that they carry
genetic information which is beyond their control to change.49
Indeed, there are documented cases of individuals being so traumatized
by learning that they carry the gene for the inevitably fatal Hunting-
ton's disease, that they committed suicide."0
Clearly, compelled testing forces an individual to face information
he or she "did not know previously, and that perhaps he or she did not
want to know."51  Once a person learns about a genetic predisposi-
tion, that knowledge cannot be undone. Thus, someone who chooses
not to know that she is at risk for a particular disease should not be
44. See Peninsula Counseling Center v. Rahm, 105 Wash. 2d 929, 932-935, 719 P.2d 926,
927-29 (1986). See also Doe v. Puget Sound Blood Center, 117 Wash. 2d 772, 783, 819 P.2d
370, 376 (1991) (declining to address the issue of whether a constitutional right to privacy can be
invoked without state action).
45. See Bornstein, supra note 14, at 572.
46. See Rothstein, supra note 27, at 898.
47. See Lori Andrews, Body Science, 83 ABA J. 44, 46 (1997). A recent incident involving
two members of the Marine Corps underscores the risk compelled genetic testing poses for
personal autonomy. Two members of the Marine Corps were court-martialed in January, 1995,
for refusing to submit to what they considered to be compelled testing. The marines resisted an
order to provide blood and saliva samples for DNA sampling. The Marine Corps contended that
it was collecting DNA from service members in order to have DNA samples available to aid in
the identification of soldiers killed at battle. However, DNA can be stored in a stable condition
for many years. The two marines were concerned that the samples might be used for genetic
testing, without their knowledge or consent, at some future date.
48. See Sack, supra note 1, at 46.
49. Rothstein, supra note 27, at 898.
50. See id. at 898 n.166.
51. Id. at 900.
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compelled to undergo testing. 52 Seen from this view, autonomy with
regard to genetic information includes a person's right to know, as well
as the right not to know, what information her DNA holds.
Maria Silverwood disclosed genetic information by way of family
history. Maria currently lives with the knowledge that she might
someday manifest symptoms of Huntington's disease, as her mother
did. However, her employer or her employer's insurance company
might have required her to submit to genetic testing, as a condition of
accepting employment. Currently, compelled genetic testing is not
prohibited either by Washington law53 or by federal law. 4 If Maria
had tested positive for the Huntington's gene, she would have been
forced to confront the knowledge that she is destined to have Hunting-
ton's disease at some unknown future date. While it is true that Maria
might also have learned that she does not carry the Huntington's gene,
the difficult choice of whether or not to face that knowledge belongs
only to Maria, not to her employer or insurance company. Specific
legislation is necessary to ensure that Washington citizens like Maria
are not required to submit to compelled genetic testing.
Loss of genetic privacy and decisionmaking autonomy are two
potential harms that careful legislation can help prevent. Additional
harms that can result from unauthorized disclosure or misuse of genetic
information are discussed in the next section.
52. Bornstein, supra note 14, at 573.
53. See Chapter 49.60, WASH. REV. CODE, prohibiting discrimination in employment, but
not addressing either genetic information or compelled testing of genetic information by
employers. See also Chapter 48.43, WASH. REV. CODE, regulating insurance but not prohibiting
compelled genetic testing by insurance companies.
54. The federal Americans With Disabilities Act (ADA) prohibits discrimination in
employment, but does not explicitly address genetic information. See 42 U.S.C. § 12112(a)
(1996). The ADA permits employers to require that employees submit to genetic testing
following an offer of employment, provided that the information obtained is not later unfairly
used. See GARY PHELAN ET AL., DISABILITY DISCRIMINATION IN THE WORKPLACE § 13:07
(1996); Andrews, supra note 47, at 47.
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IV. HARMS FROM UNAUTHORIZED DISCLOSURE AND MISUSE OF
GENETIC INFORMATION
In addition to loss of genetic privacy and autonomy, other harmful
outcomes can result when genetic information is misused or disclosed
without authorization.
A. Undermining of the Physician-Patient Relationship
The unauthorized release of genetic information undermines the
physician-patient relationship. Patients expect that information shared
with their physician will remain confidential."5 The disclosure of
personal, private information is an insult to dignity, and signals a lack
of respect for the individual.5 6 In addition, patients are reluctant to
be completely forthcoming with information in a clinical setting if they
are not certain the disclosed information will remain confidential.57
Thus, a patient who thinks his family history or genetic test results
will not remain confidential may withhold that information from his
physician, especially if the patient fears the disclosure may jeopardize
his insurance benefits.5" Withholding this information potentially
interferes with the physician's ability to diagnose and treat the patient
effectively. 9 Therefore, a patient must be assured that any knowl-
edge his physician has regarding genetic information will remain
confidential.60  Otherwise, effective treatment and diagnosis are
compromised.
B. Failure to Realize the Potential Benefits from Genetic Testing
Genetic testing can identify some genetic conditions which are not
certain to occur.61 As a result, some individuals stand to benefit by
making lifestyle changes which might drastically decrease the chances
of a diagnosed genetic condition ever manifesting itself.62  For
example, genetic testing will soon be able to identify some individuals
at risk for heart disease.63 A person who learns through genetic
testing that she carries this risk can make lifestyle changes (such as diet
55. See Rothstein, supra note 27, at 896.
56. Gostin et al., supra note 30, at 23.
57. See Rothstein, supra note 27, at 897. See also Gostin et al., supra note 30, at 20.
58. See Rothstein, supra note 27, at 897.
59. See id. at 896.
60. See id.
61. See Bornstein, supra note 14, at 560.
62. See Blake, supra note 22, at 872.
63. See Bornstein, supra note 14, at 560.
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and exercise) to reduce the likelihood that she will ever actually
experience heart disease.64 Yet this same person might avoid testing
unless she knows that the test results will be kept confidential,
especially if she knows that the test results could be used to discrimi-
nate against her in employment or insurance.
C. Reproductive Discrimination
Opponents to the Human Genome Project and the development
of genetic testing fear that genetic information will be used for eugenic
purposes.6" A person's genetic code contains information about traits
which are immutably a part of that person. Significantly, certain
genetic traits, including predisposition to disease, tend to fall along
ethnic and racial lines. 66 The fear exists that certain races and ethnic
groups will be selectively targeted for genetic testing and forced
sterilization under the guise of trying to eliminate certain genetic
diseases from the overall gene pool.67 Given that genetic information
has been misused for eugenic purposes in the United States during this
century, the danger of reproductive discrimination on the basis of
racially associated genetic characteristics is a very real concern.6" The
elimination of certain genetic diseases from the population may be
beneficial, but not at the expense of the right to bear children. The
right to procreate is firmly established in the United States, even if
bearing children means perpetuating an undesirable trait.69
64. See Blake, supra note 22, at 872.
65. Eugenics is improvement of the human race by encouraging individuals with desired
traits to reproduce, while preventing reproduction of those individuals with undesirable traits.
The most widely known eugenics movement was seen in Nazi Germany through the sanctioning
of mass sterilization and extermination of individuals seen as undesirable because of their
ethnicity, religion, or sexual orientation. In the United States, laws which allowed sterilization
of certain groups (such as the mentally retarded) were overturned by the Supreme Court in 1942.
See Skinner v. Oklahoma, 316 U.S. 535 (1942); Rothstein, supra note 27, at 894. See also Smith,
supra note 3, at 123.
66. See Smith, supra note 3, at 123. See also Rothstein, supra note 27, at 877.
67. See Smith, supra note 3, at 123.
68. See In re Primus, 436 U.S. 412 (1978) (discussing reports that pregnant mothers on
public assistance were being sterilized or threatened with sterilization as a condition of continuing
to receive welfare benefits). See also Rothstein, supra note 27, at 894 (1996).
69. See Skinner v. Oklahoma, 316 U.S. at 535.
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D. Economic Harm
1. Genetic Discrimination in Insurance
It is well documented that insurance companies discriminate on
the basis of genetic information. 70  The resulting economic harm is
significant, and includes increased premiums and denial of benefits.7'
Maria Silverwood experienced genetic discrimination when she was
denied the opportunity to purchase disability insurance through her
employer. As a result, she was forced to forgo the insurance and to
risk financial hardship should she unexpectedly become disabled by an
injury. Alternatively, she could purchase private disability insurance
at a much higher premium.
Insurance companies justify discrimination in rates and coverage
because they are in the business of risk spreading. They view genetic
information as being like any other information they scrutinize in
making decisions about ratings and coverage. In other words, insurers
believe they should be able to use genetic risk to classify applicants as
a means of assigning risk, just as they use other risk factors (such as
smoking) or pre-existing conditions (such as heart disease). 72  From
an insurer's perspective it is rational to discriminate on the basis of
genetic information. According to this view, people with either a
family history or a confirmed diagnosis of a genetic condition are
presumed to use more services; thus they should either pay higher rates
or be denied coverage altogether.73
The insurance industry's approach to genetic information,
however, contradicts public policy. Many people who carry a defective
gene will never manifest symptoms of a genetic condition.74 Yet,
insurance companies burden these individuals with higher premiums,
or loss of insurance altogether, because they might be at risk of
displaying certain disease symptoms in the future.75 In addition,
insurers ignore the impact that lifestyle changes have on reducing the
likelihood that symptoms of a genetic disease will develop. Moreover,
denial of life and health insurance coverage on the basis of genetic
70. See E. Virginia Lapharn et al., Genetic Discrimination: Perspectives of Consumers, 274
SCIENCE 621 (1996).
71. See id.
72. See Jill Gauling, Race, Sex, and Genetic Discrimination in Insurance: What's Fair?, 80
CORNELL L. REV. 1646, 1687 (1995).
73. See id.




information has negative social consequences: denial of life insurance
leaves dependents economically vulnerable, and denial of health
insurance means more people will be dependent on the social welfare
system for medical care.76 Overall, insurance coverage must be
viewed as an important public good, which should be more available
rather than less available.77
2. Genetic Discrimination in Employment
As with insurance, genetic discrimination in employment is well
documented. 7' Economic harm results when prospective employers
reject applicants or deny employees the opportunity for promotion on
the basis of genetic information.79
Employers have incentives to make employment decisions based
on genetic information for several reasons. These include the risk of
increased health insurance premiums, increased absenteeism, and
decreased productivity.80 However, an employer who uses genetic
information to make employment decisions is essentially treating the
affected employee as if she is disabled or handicapped. Significantly,
employment discrimination laws (federal and state) prohibit employ-
ment discrimination against disabled or handicapped individuals.8"
These laws protect employers from discriminating against employees
who "express," or outwardly display, symptoms of a genetic condition.
It is extremely difficult to prove that an employer's hiring or promo-
tion decision was based on an employee's genetic information when no
disease symptoms are present, rather than some other factor. As a
result, antidiscrimination laws appear to offer little protection from
genetic discrimination in employment. 2
76. See Roberta M. Berry, The Human Genome Project and the End of Insurance, 7 U. FLA.
J. L. AND PUB. POL'Y 205, 232-33 (1996).
77. See Andrews, supra note 47, at 47 (stating "[c]arried to its extreme, that approach to
coverage could make everyone uninsurable, since every human being carries between eight and
12 'defective' genes that might trigger various medical disorders.") See also Bornstein, supra note
14, at 558.
78. See Lapham et al., supra note 70, at 621-23.
79. See id. at 621.
80. Smith, supra note 3, at 125.
81. Frank C. Morris et al., Privacy and Defamation in Employment, in EMPLOYMENT
DISCRIMINATION AND CIVIL RIGHTS ACTIONS IN FEDERAL AND STATE COURTS: ALI-ABA
COURSE STUDY MATERIALS 559, 582 (1996).
82. The Americans with Disabilities Act of 1980 was an attempt on the part of the federal
government to prohibit discrimination in the workplace based on handicap or disability. See 42
U.S.C. §§ 12101-12213 (1994). The ADA, which is administered by the Equal Opportunity
Employment Commission (EEOC), broadly defines disability as:
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The harms described in this section can largely be prevented by
legislation specifically tailored to protect genetic privacy and prohibit
genetic discrimination. The next section examines legislative efforts
directed toward these goals, first at the federal level, then in states
other than Washington, and finally in Washington.
V. PROTECTION OF GENETIC PRIVACY: FEDERAL
AND STATE LEGISLATION
Currently, there is no comprehensive federal protection of genetic
privacy or prohibition against genetic discrimination. In the absence
of federal legislation, many states have enacted laws regulating access
and use of genetic information. 3 This section explores the current
status of both federal and state laws which regulate genetic informa-
tion.
A. Federal Legislation
Eleven separate bills which proposed regulating genetic informa-
tion were introduced during the 104th Congress (1995-96). Eight of
the bills specifically proposed protections against genetic discrimina-
tion, but none was passed into law. 4 Three were directed toward
ensuring health insurance portability and coverage.8 5 Of these three,
one was signed into law as the Health Insurance Portability and
Accountability Act of 1996 (HIPAA). 6
(A) a physical or mental impairment that substantially limits one or more of the major
life activities of such individual;
(B) a record of such an impairment; or
(C) being regarded as having such an impairment.
42 U.S.C. § 12102(2) (1994).
While the ADA itself does not explicitly refer to genetic information, the EEOC compliance
manual suggests that discrimination on the basis of a predisposition to a particular genetic disease
would be prohibited by part (C) of this definition. See EEOC Compliance Manual § 902.8; see
also PHELAN ET AL., supra note 54, at § 13:01 (1996). In other words, a person diagnosed with,
but not displaying symptoms of, a genetic disease cannot be discriminated against in employment
because he is "regarded as having an impairment." See EEOC Compliance Manual § 902.8.
However, it is very difficult for employees to prove that they are denied employment or
promotions on the basis of genetic information, rather than on some other factor. As of this
writing, no case law was identified where a plaintiff like Maria Silverwood challenged an
employer's alleged genetic discrimination under the ADA. Consequently, it is unclear what the
chances are of a plaintiff like Maria prevailing on such a claim brought under the ADA.
83. See Andrews, supra note 47, at 47.
84. See S. 1416 (identical to H.R. 2690), H.R. 2748, S. 1600, S. 1694, H.R. 3482, H.R.
3477, S. 1898, H.R. 4008, 104th Cong. (1996).
85. See H.R. 3103 (substituted and combined with H.R. 3160), H.R. 3034, H.R. 3185,
104th Cong. (1996).
86. Pub. L. No. 104-191 (codified at 42 U.S.C. § 201 (1996)).
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HIPAA ensures that employees are able to maintain health care
coverage when they change jobs. Genetic information is protected
under this bill only to the extent that health insurance plans may not
use genetic information as a factor when determining eligibility for
coverage. 7 While this is an encouraging first step toward protecting
genetic information and preventing genetic discrimination, the bill has
been criticized for failing to include specific language protecting the
confidentiality of patient health information." Thus, under HIPAA,
genetic records are still vulnerable to unauthorized redisclosure8 9
Protecting genetic privacy continues to be a major topic of interest
to federal legislators.90 The issue gained national attention during a
recent White House briefing, when President Clinton endorsed the
bipartisan legislative efforts of Representative Louise Slaughter (Dem.,
N.Y.) and Senator Olympia Snowe (Rep., Maine).91 Senator Snowe
introduced the Genetic Information Nondiscrimination in Health
Insurance Act of 1997 in the Senate on January 21, 1997.92 Repre-
sentative Slaughter sponsored similar legislation in the House of
Representatives as part of the Children's National Security Act.93 In
addition to these two bills, three others have been introduced to
Congress since January 1, 1997. 9'
Bipartisan support and presidential endorsement suggest that some
form of federal legislation protecting genetic privacy has a reasonable
chance of becoming law in the near future. However, passage of such
87. See 26 U.S.C. § 9802(a)(1)(F) (1996).
88. See Medical Records: Rep. McDermott Introduces Measure to Protect Health Information
Privacy, HEALTH CARE DAILY REP. (BNA), May 22, 1996 at D15. See also Medical Records:
Role of Preemption, Genetic Data in Federal Privacy Standards Debated, HEALTH CARE DAILY
REP. (BNA), June 6, 1997, at D6. Under HIPAA, Congress must enact comprehensive
legislation to protect health record privacy by mid-August 1999. Otherwise, the Health and
Human Services department is mandated to issue regulations which establish federal privacy
standards to protect electronically transmitted information. See HEALTH CARE DAILY REP.
(BNA), June 6, 1997, at D6. H.R. 52, introduced to the House of Representatives on January
27, 1997, is designed to meet the HIPPA records privacy requirement, and would establish federal
framework for protecting health information. See H.R. 52, 105th Congress (1997).
89. See HEALTH CARE DAILY REP. (BNA), May 22, 1996, at D15.
90. See Carol Smith, Clinton Backs Genetics Discrimination Bill, SEATTLE POST
INTELLIGENCER, July 15, 1997 at B1, 1997, WL 3201511.
91. Id.
92. S. 89, 105th Cong. (1997).
93. H.R. 1726, 105th Cong. (1997).
94. S. 422, 105th Cong. (1997), (proposing the Genetic Confidentiality and Nondiscrimina-
tion Act of 1997, introduced in the Senate on March 11, 1997 by Sen. Domenici); H.R. 1815,
105th Cong. (1997) (proposing the Medical Privacy in the Age of New Technologies Act of 1997,
introduced in the House of Representatives on June 5, 1997, by Rep. McDermott); H.R. 2198,
105th Cong. (1997) (proposing the Genetic Privacy and Nondiscrimination Act of 1997,
introduced in the House of Representatives on July 17, 1997 by Rep. Steams).
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federal legislation will not fully resolve the issue, because it will raise
new questions regarding federal preemption of individual state efforts
to protect genetic privacy.95
In the meantime, given the uncertainties surrounding federal
legislation, many states have taken their own affirmative steps to
protect their citizens from invasions of genetic privacy.
B. Legislation in States Other than Washington
To date, fourteen states have taken affirmative measures to protect
their citizens from invasions of genetic privacy and from potential
genetic discrimination, using a variety of different approaches.96 One
approach is to expand state law pertaining to the confidentiality of
health records by including specific provisions to protect genetic
information. 7  Other approaches include explicitly prohibiting
employers from using genetic information to discriminate, prohibiting
insurers from requiring genetic tests, and prohibiting the use of
information derived from genetic testing in making decisions regarding
coverage.
98
State laws that prohibit genetic discrimination in health insurance
have been described as a "hollow victory," because the laws do not
apply to all insurance plans.99 State laws apply only to insurance
which is directly purchased either by consumers, or by employers on
behalf of their employees. 00 They do not apply to employer-based
health insurance plans that are self-insured, where the employer
assumes the risks typically associated with insurance plans,'0 ' because
the application of state laws to self-insured plans is explicitly preempt-
95. See HEALTH CARE DAILY REP. (BNA), supra note 88, June 6, 1997, at D6.
96. The following states have enacted legislation regulating disclosure and/or use of genetic
information: Virginia, Iowa, New Hampshire, New Jersey, New York, Oregon, Rhode Island,
Wisconsin, Georgia, Maryland, Minnesota, Ohio, and Colorado. See generally Andrews, supra
note 47.
97. Colorado has taken this approach and provided statutory protection to information
derived from genetic testing. See COLO REv. STAT. ANN. § 10-3-1104.7 (West 1994).
98. Iowa, New Hampshire, New Jersey, New York, Oregon, Rhode Island, Texas and
Wisconsin have laws prohibiting employers from using genetic information to discriminate.
Colorado, Oregon and Texas prohibit insurance companies from denying coverage or changing
coverage ranges based on genetic test results. New Hampshire, New Jersey, Georgia, Maryland,
Minnesota and Ohio prohibit insurance companies from requiring genetic testing, in addition to
prohibiting insurance companies from making policy decisions based on genetic test results. See
Andrews, supra note 47, at 44 (1997).
99. Id.
100. Id.
101. See Margaret G. Farrell, ERISA and Managed Care: The Law Abhors a Vacuum, 29
J. OF HEALTH & HOSP. L. 268, 269 (1997).
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ed by federal law under the Employee Retirement Income Security Act
of 1974 (ERISA).0 2 Significantly, the majority of people in this
country obtain their health insurance through employer self-funded
insurance plans. 10 3  As a consequence, ERISA preemption of state
laws aimed at prohibiting genetic discrimination in health insurance
makes those laws meaningless to the majority of Americans. 4
ERISA preemption underscores the need for federal legislation to
prohibit genetic discrimination in health insurance.'015
The next section examines Washington law, analyzing the
Washington State Health Care Information Access and Disclosure
Act'06 and concluding that this law is inadequate to protect genetic
privacy and to prevent genetic discrimination in Washington. The
final section presents a substantive proposal for a Washington State
Genetic Privacy Act, which would ensure that the Maria Silverwoods
of our state do not experience invasions of genetic privacy and genetic
discrimination.
C. Protection of Genetic Privacy In Washington State: Current Law
The Washington legislature enacted the Health Care Information
Access and Disclosure Act in 1991 (hereinafter the Disclosure
Act). 7 The Disclosure Act was adopted following a legislative
finding that "[h]ealth care information is personal and sensitive
information that if improperly used or released may do significant
harm to a patient's interests in privacy, health care, or other inter-
ests."'0 8  Adoption of the Disclosure Act was consistent with the
102. 29 U.S.C.A. § 1114 (West 1994). A detailed discussion of ERISA is beyond the scope
of this article. For discussions regarding ERISA preemption and insurance, see generally Farrell,
supra note 101, at 268; Catherine L. Fisk, The Last Article About the Language of Erisa
Preemption? A Case Study of the Failure of Textualism, 33 HARV. J. ON LEGIS. 35, 43-52 (1996);
Allison Overbay and Mark Hall, Insurance Regulation of Providers That Bear Risk, 22 AM. J.L.
& MED. 361, 379-385 (1996).
103. See Farrell, supra note 101, at 269.
104. See Andrews, supra note 47, at 44.
105. See Smith, supra note 3, at 122.
106. WASH. REV. CODE § 70.02 (1996).
107. Id. The Disclosure Act was modeled after the Uniform Health Care Information Act,
which was developed by the National Conference of Commissioners on Uniform State Laws in
1984. To date, only two states (Washington and Montana) have adopted this uniform law.
108. "Health care information" is defined in title 70, chapter 2 of the Washington Revised
Code as "any information, whether oral or recorded in any form or medium, that identifies or can
readily be associated with the identity of a patient and directly relates to the patient's health care.
The term includes any disclosure of health care information." WASH. REV. CODE § 70.02.010
(1996).
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high regard for protection of personal privacy which is defined in the
Washington State Constitution. 9
The Disclosure Act's legislative history indicates that it was seen
as necessary to help patients overcome difficulty "in obtaining access
to their medical and health records."" The legislature acknowl-
edged that changes in the processing of health care information
(including insurance audits, health care research, and use of computers)
threaten the confidentiality of information in individual medical
records."' Thus, the legislative intent behind the Disclosure Act
was to provide "specific standards for information disclosure by health
care providers and facilities, and guarantee of access to vital health care
information by clients." '  Prior to passage, testimony in support of
the original bill was provided by, among others, Group Health
Cooperative of Puget Sound and the Washington State Medical
Records Association." 3  No testimony was presented in opposition
to the Disclosure Act.1 14
Under the Disclosure Act, health care providers must obtain
written authorization before disclosing patient health care informa-
tion." ' With limited exceptions, such an authorization for disclosure
is subject to revocation by a patient at any time." 6 Disclosure of
health care information without patient authorization is allowed under
specific circumstances, such as to another provider treating the patient,
in order to avoid or to minimize an imminent danger to the safety or
109. Artide 1, § 7 of the Washington State Constitution states, "No person shall be
disturbed in his private affairs, or his home invaded, without authority of law." WASH. CONST.
art. 1, § 7.





115. WASH. REV. CODE § 70.02.020 (1996). The statute provides, in part:
Except as authorized in RCW 70.02.050, a health care provider, an individual who
assists a health care provider in the delivery of health care, or an agent and employee
of a health care provider may not disclose health care information about a patient to any
other person without the patient's written authorization.
Id.
116. WASH. REV. CODE § 70.02.040 (1996). The statute states:
Patient's revocation of authorization for disclosure. A patient may revoke in writing a
disclosure authorization to a health care provider at any time unless disclosure is
required to effectuate payments for health care that has been provided or other
substantial action has been taken in reliance on the authorization. A patient may not
maintain an action against the health care provider for disclosures made in good-faith
reliance on an authorization if the health care provider has no actual notice of the
revocation of the authorization.
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health of the patient or some other individual, or in order to provide
directory information. 17
Prior to adoption of the Disclosure Act, no clear case law or
statutory guidelines existed in Washington regarding the confidentiality
of health care records."' 8 Consequently, the Disclosure Act was a
significant step toward ensuring the privacy of health care information
for Washington citizens. However, the Disclosure Act does not go far
enough to ensure protection of genetic privacy and prevention of
discrimination on the basis of genetic information for several reasons.
First, all health care information is treated equally under the Disclosure
Act. Genetic information is a unique type of personal information
because it predicts a future result rather than simply diagnosing a
present ailment. 9  As such, genetic information should receive
special consideration beyond that provided for health care information
in general by the Disclosure Act. The Washington legislature has
previously recognized that several types of health care information
require special statutory protection. Under Washington law, test
results for HIV and sexually transmitted disease infections are given
special protection from unauthorized disclosure. 20 Similarly, genetic
information deserves consideration as a class of information separate
from other health care information.
Second, under the Disclosure Act, disclosure of genetic informa-
tion can be made under a general authorization for the release of
medical or other information. The first time a patient visits a
particular physician or clinic, the patient typically fills out a medical
history and signs a form authorizing disclosure of information to the
patient's insurance carriers for purposes of billing. The disclosure
form makes virtually all health care information in the patient's file
accessible to the health insurance carrier, including information not
directly related to services for which the carrier reimburses the health
care provider. 2 ' The disclosure form also acts as a general blanket
authorization which is effective for the duration that the patient
receives health care from that particular provider. Even though this
authorization to disclose can be revoked under the Disclosure Act, 122
117. See WASH. REV. CODE § 70.020.050 (1996).
118. See Peninsula Counseling Center v. Rahm, 105 Wash. 2d 929, 719 P.2d 926 (1996)
(discussing release of patient information to government officials without defining parameters for
disclosure to nongovernmental parties).
119. See discussion, supra Part 11.
120. See WASH. REV. CODE § 70.24.105 (1996).
121. See WASH. REV. CODE § 70.02.030 (1996).
122. See WASH. REV. CODE § 70.02.040 (1996).
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it is unlikely that most patients are aware of their right to revoke. More
significantly, some insurance carriers make release of information a
condition of coverage by a health insurance policy, leaving patients in
a position of signing or losing coverage.1
Third, the Disclosure Act does not do enough to protect against
redisclosure of health care information after an authorized disclosure
is made. For example, once health care information is legitimately
disclosed, either to an insurance carrier under a blanket authorization
or by specific written authorization, there is no specific prohibition in
the Disclosure Act concerning redisclosure of that information. In
other words, employers, potential employers, or others might gain
access to information through redisclosure, without the knowledge or
approval of the particular patient involved. The potential for
redisclosure raises enormous concerns over who might potentially
access genetic information, and how that information might be used or
misused. Employers might use the information to determine whether
or not to promote an employee, as in Maria Silverwood's case.
Financial institutions could use the information to decide whether or
not to loan money to a particular person. While redisclosure of genetic
information has some legitimate purposes, such as use for medical
research, 2 4 the risk of misuse of redisclosed information certainly
outweighs any potential benefits. Consequently, genetic information
needs greater protection than is provided under the Disclosure Act in
order to prevent unauthorized redisclosure. 2'
Fourth, the Disclosure Act also allows too much latitude for
disclosure without patient authorization under its exceptions for
specific circumstances. For example, oral disclosure of health care
information is allowed under the Disclosure Act to family members or
significant others, unless the patient has instructed the provider not to
make the disclosure.'26 Under this provision, disclosure of genetic
123. A useful analogy is that of an adhesion contract, where there is a disparity in bargain-
ing power between the parties to a contract. Consumers do not typically have the opportunity
to bargain over the terms of their insurance policies, especially when policies are obtained through
employers. As a result, consumers often have no choice but to accept a term which might be
unfavorable to them, such as disclosure of all medical information as a condition of accepting
coverage.
124. See Rothstein, supra note 27, at 892.
125. Redisclosure following legitimate disclosure of test results for HIV and sexually trans-
mitted diseases is specifically prohibited under title 70, chapter 24 of the Washington Revised
Code. See WASH. REV. CODE § 70.24.105 (1996).
126. Title 70, chapter 2 of the Washington Revised Code allows disclosure without patient's
authorization to be:
Oral, and made to immediate family members of the patient, or any other individual
with whom the patient is known to have a dose personal relationship, if made in
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information is allowed by default, and nondisclosure is the excep-
tion.'27 To protect genetic privacy and autonomy, disclosure must
be made only by the choice of the individual the information pertains
to. Disclosure to family members or anyone else cannot be allowed by
default.'28
Finally, the Disclosure Act allows for denial of patient access to
health care information under certain circumstances. For example, a
health care provider may deny access to health care information if the
provider concludes that the information would be injurious to the
health of the patient.'29 This situation does not appropriately apply
when considering genetic information. The reason a person would
undergo testing would be to learn more about the status of his or her
own health. Denial of access to genetic test results runs directly
counter to the opportunity available to people, through testing, to learn
more about their own health status. Further, individuals are more
likely to forgo genetic testing if they can be denied access to, and
control of, their test results. Consequently, the Disclosure Act fails to
protect individual autonomy regarding genetic information, especially
regarding results of genetic testing, by allowing potential denial of
access to individual genetic test results.
As the above discussion clearly demonstrates, the Disclosure Act
is an inadequate vehicle to protect genetic privacy or to provide
individual autonomy and control over genetic information. 3 °
accordance with good medical or other professional practice, unless the patient has
instructed the health care provider in writing not to make the disclosure.
WASH. REV. CODE § 70.02.050(1)(e) (1996).
127. See id.
128. See generally WASH. REV. CODE § 70.02.050 (1996).
129. See WASH. REV. CODE § 70.02.090(1)(a) (1996).
130. However, Washington lawmakers appear to be aware of the need to give genetic
privacy special statutory protection. During the 1997 legislative session, a bill was introduced in
the Senate which addressed discrimination by health carriers on the basis of genetic information.
Senate Bill (SB) 5298 proposed adding a new section to title 48, chapter 43 of the Washington
Revised Code, which regulates health insurance providers. SB 5298, 55th Leg., 1st Reg. Sess.
(Wash. 1997). Under SB 5298, health insurance providers would have been prohibited from
denying or canceling coverage on the basis of the genetic information of individuals or family
members. Redisclosure following an authorized disclosure would also have been prohibited. SB
5298 failed to pass out of the Committee on Health and Long Term Care, and the bill was
pronounced "dead" before the end of the 1997 legislative session.
While SB 5298 was an encouraging sign that Washington lawmakers are aware of the need
to give genetic information special statutory protection, the bill was presented only in the context
of health insurance regulation. Consequently, the bill did not go far enough to accomplish
comprehensive protection of personal privacy and autonomy with regard to genetic information.
In addition, while the bill attempted to prevent discrimination in health insurance, genetic
discrimination in life insurance, disability insurance, and employment was not addressed.
Moreover, if enacted, the law would have "related to" insurance, and would have been subject to
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Consequently, Washington lawmakers need to enact specific legislation
to address the limitations of the Health Care Information and
Disclosure Act with respect to genetic information. Lawmakers must
also address issues which are beyond the scope of the Disclosure Act,
such as the prohibition of unauthorized or compulsory genetic testing
and the destruction of samples following testing. The next section
suggests what the legislation should substantively contain in order to
provide Washington citizens with statutory protection of their genetic
information.
VI. PROPOSAL FOR A WASHINGTON STATE GENETIC
PRIVACY ACT
In designing legislation aimed at protecting genetic information,
it is important to keep in mind the important functions to be served by
legislation aimed specifically at protecting the privacy of genetic
information. First, the privacy of information which is personal and
unique would be assured. Second, autonomy in decisionmaking
regarding personal health care would be maintained. Finally,
discrimination on the basis of genetic information would be prevented.
Accomplishing comprehensive protection of genetic information
requires regulating all stages of the genetic testing process, from sample
collection through access of genetic information in a patient's medical
records. In order to provide this comprehensive protection, legislators
should enact a Washington State Genetic Privacy Act (WSGPA),
containing provisions which address each of the issues detailed below.
A. Definition of Genetic Information
The WSGPA should define "genetic information" broadly to
include both the results of genetic testing and any information about
inherited characteristics obtained from family history.131
In contrast to this broad definition, some approaches to protecting
genetic privacy have limited genetic protection only to the results of
testing by DNA analysis, thereby excluding family history information
from the range of protected information.Y12  However, family history
information about inherited diseases is also a legitimate source of
federal preemption under ERISA. As a result, the law would not have applied to the many
Washington citizens who obtain their health insurance through self-insured plans. See Smith,
supra note 3, at 124.
131. An appropriate definition of genetic information was the one set forth in Senate Bill
5298, where "genetic information" was broadly defined as "information about genes, gene
products, or inherited characteristics." SB 5298, supra note 130.
132. See, e.g., ANNAS ET AL., supra note 10, at 45-48.
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genetic information. In fact, family history has long been used as a
tool for making predictions about individual genetic characteristics.
13
As Maria Silverwood learned, genetic information gleaned from family
history is as likely to result in discrimination by insurance and
employers as is information obtained from genetic testing. Conse-
quently, genetic information drawn from family history must be within
the range of information which is given statutory protection by the
WSGPA if prevention of genetic discrimination is to be ensured.
B. Prohibition of Unauthorized Sample Collection and Testing
The unauthorized collection of samples for genetic testing must
be prohibited by the WSGPA. Typically, genetic material is collected
for testing by a simple blood draw. Ample DNA can be obtained
from the cells in a small volume of blood for conducting the desired
genetic test. However, it is also possible to obtain DNA from
individuals without their knowledge. For example, DNA can be
collected from hair, saliva, and other bodily tissues and fluids which
could possibly be collected without an individual's consent.134 Thus,
sample collection, prior to testing, must require specific authorization
by the person who desires testing. To ensure that no unauthorized
sample collection occurs, laboratories performing testing must be
required to ensure that samples are accompanied by documentation
authorizing sample collection.
C. Prohibition of Compelled Testing
The WSGPA must prohibit any compulsory genetic testing. As
discussed above, the decision to undergo genetic testing is a very
personal and difficult one to make. The rights of individuals who
choose not to undergo genetic testing must be protected.
Employers and insurance companies argue that they are left
without access to all potentially available information regarding
employees and enrollees without compulsory testing.13  These
concerns are far outweighed by the individual's right to privacy about
one's own body and autonomy in personal decisionmaking, both of
which are threatened by compulsory testing. The ability to make
personal decisions without government interference is recognized by
133. See Bornstein, supra note 14, at 598.
134. See ANNAS ET AL., supra note 10, at vi.
135. See Gauling, supra note 72, at 1686.
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the United States Supreme Court and the Washington Supreme
Court.' 36 It follows that the personal decision of whether or not to
undergo genetic testing should not only be free from government
interference and compulsion, but also free from interference or
compulsion by private parties, such as employers and insurance
companies.
Under current Washington law, employers and insurers are not
prohibited from requiring genetic testing as a condition of employment
or insurance coverage. This type of compelled testing comes at a price:
the opportunity to make the independent choice of whether to undergo
genetic testing is lost forever. This choice can be preserved for the
person to whom it means the most if employers and insurers are
prohibited from requiring genetic testing. The WSGPA must prohibit
compulsory genetic testing in order to preserve personal autonomy in
the decision of whether to undergo genetic testing.
D. Stringent Rules Regarding Authorized Disclosure and Redisclosure
Under the WSGPA, disclosure of genetic information must not
be allowed on the basis of a general, blanket authorization of the type
often used to release general medical information to insurance
companies for reimbursement verification. Disclosure must only occur
if there is written authorization allowing release of genetic information
to a specific individual. Exceptions comparable to those found in the
Disclosure Act (allowing unauthorized disclosure) must not be
permitted. Any authorization must include a reasonable expiration
date, such as thirty days after the patient signs the authorization.
Further, any disclosure must be revocable, and the authorization
must inform the patient of her right to revoke. To ensure that the
patient is aware of the possibility of revocation, the authorization form
should include a separate section explaining that the authorization can
be revoked. This section should be brought to the patient's attention,
and initialed by her to verify that she has read and understood it.
The recipient of the information must be notified upon receipt of
the information that the disclosure is confidential, and the information
must not be redisclosed without the specific written consent of the
patient.'37 For example, if an individual voluntarily discloses genetic
information to a health or life insurance carrier, that carrier must be
136. See Whalen v. Roe, 429 U.S. 589, 599-600 (1977); Peninsula Counseling Center v.
Rahm, 105 Wash. 2d at 934-35, 719 P.2d at 928-29 (adopting Whalen v. Roe).
137. See WASH. REV. CODE § 70.24.105(5) (1996) (regarding the disclosure of HIV and
sexually transmitted disease test results).
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prohibited from disclosing the information to any other parties. In this
manner, carriers or others who legitimately receive information are
prohibited from selling the information on the "personal information
market," or otherwise misusing the information. This will also help
assure that disclosed genetic information will be put only to the limited
use for which the patient gave the original authorization.
Further, if a patient authorizes release of information to claims
management personnel associated with an insurer, the information may
only be used for the purpose of prompt payment and evaluation of any
medically related claims. 3 ' Claims payment personnel must be on
notice that the specifics of the information must not be redisclosed.
E. Assurance of Access
Under Washington's Health Care Information Access and
Disclosure Act, patients may be denied access to their own medical
records under certain circumstances.' 39 For example, a health care
provider may deny a patient access to her own medical records if the
provider believes that the information would be injurious to the
person's health.
40
Access to genetic information, however, should never be subjected
to such a restriction. A person who chooses to undergo genetic testing
does so in order to learn more about her own health status. Unrestrict-
ed access to testing results is necessary to give that person the
maximum benefit that can be derived from having the testing done.
This is particularly important in cases such as testing for a predisposi-
tion for conditions such as heart disease, where life style changes are
known to influence the likelihood of whether or not the disease will
manifest itself. Clearly, rather than the knowledge of a genetic
predisposition being potentially injurious to a person's health, denial
of access to genetic information would be injurious by denying a
person the opportunity to take advantage of the testing. Consequently,
in order to both allow individual control over genetic information and
maximize the potential benefits of testing, access to individual genetic
information should never be denied. The WSGPA must include an
assurance of a person's access to any and all testing results.
138. See id.
139. See WASH. REV. CODE § 70.02.090 (1996).
140. See id. (allowing denial of access and copying of medical records if "[k]nowledge of the
health care information would be injurious to the health of the patient.").
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F Destruction of Samples
Typically, genetic testing involves a simple blood draw from a
person, since DNA can be extracted from the cells in the blood. Once
extracted, the DNA is stable for long periods of time if frozen. As
technology progresses, it may be possible to obtain more and more
information from samples collected at some previous date. The storage
potential for DNA suggests a risk of unauthorized testing, and
consequently of unauthorized release of genetic information.'41
Since blood samples are typically very simple to collect, an original
sample should be destroyed after analysis for the specific genetic
condition the sample was collected for. An additional blood sample
can be collected at a future date if a person wishes to have more testing
done. Destruction of samples will reduce the risk of unauthorized
testing and disclosure of genetic information, and must be required by
the WSGPA.
G. Prohibition of Genetic Discrimination
Legislation incorporating the safeguards described above would be
significant progress toward protecting the privacy of individual genetic
information. In some cases, however, individuals might voluntarily
disclose genetic test results to employers and insurance companies. In
order to be certain that no person is discriminated against on the basis
of genetic information, the WSGPA must contain explicit prohibitions
on discrimination in insurance and employment on the basis of genetic
information which is voluntarily disclosed.
1. Insurance
Current Washington law does not expressly prohibit genetic
discrimination in health insurance. Under title 48, chapter 3, section
25 of the Washington Revised Code, a health insurance carrier may
not "deny, exclude, or otherwise limit coverage" on the basis of any
pre-existing medical condition. 14 2  Arguably, a genetic condition
141. See Andrews, supra note 47, at 44.
142. WASH. REV. CODE § 48.43.025(1) (1996). The statute provides:
No carrier may reject an individual for health plan coverage based upon any preexisting
conditions of that individual and no carrier may deny, exclude, or otherwise limit
coverage for an individual's preexisting health conditions; except that a carrier may
impose a three-month benefit waiting period for preexisting conditions for which
medical advice was given, or for which a health care provider recommended or provided
treatment within three months before the effective date of coverage.
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identified through genetic testing would be considered to be a
"preexisting condition." '143 As a result, Washington citizens may
well be protected under existing law from having the results of genetic
tests used to discriminate against them in health insurance.'44
Nonetheless, the WSGPA must expressly prohibit genetic
discrimination for all types of insurance. A comprehensive prohibition
on genetic discrimination in insurance would be consistent with the
existing law, because genetic discrimination in health insurance would
continue to be prohibited by statute. Under the WSGPA, the scope
of protection against genetic discrimination in insurance would be
expanded to include life and disability insurance, as well as in health
insurance.
Unfortunately, the WSGPA insurance provisions would not
protect all Washington citizens from potential genetic discrimination
in insurance. State laws that "relate to" insurance do not apply to self-
insured plans because of federal preemption under ERISA."4' Since
the WSGPA insurance provisions would probably be found to "relate
to" insurance, these provisions would not apply in situations where
insurance is obtained through employer-based self-insured plans.'46
Nonetheless, the WSGPA would provide protection from genetic
discrimination for Washington citizens who directly purchase their own
insurance, as well as those who obtain insurance through employers
who directly purchase insurance. 47
2. Employment
Under the WSGPA, employers must be prohibited from
discriminating in any manner on the basis of genetic information, in
order to protect both current and potential employees. 4 ' Thus, to
protect potential employees, employers must not be allowed to use
143. See Smith, supra note 90, at bl.
144. See id.
145. Farrell, supra note 101, at 268-69.
146. See Smith, supra note 90, at bl; Farrell, supra note 101, at 268-69.
147. Smith, supra note 90, at bl.
148. A useful approach is the one taken by New York state, which considers discrimination
on the basis of genetic predisposition to be a violation of their Human Rights Law. Specifically,
N.Y. Exec. Law § 296 (McKinney 1997) states:
Unlawful discriminatory practices. 1. It shall be an unlawful discriminatory practice:
(a) For an employer or licensing agency, because of the age, race, creed, color, national
origin, sex, disability, genetic predisposition or carrier status, or marital status of any
individual, to refuse to hire or employ or to bar or to discharge from employment such
individual or to discriminate against such individual in compensation or in terms,
conditions, or privileges of employment.
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genetic information when making hiring decisions. To protect current
employees, employers must be prohibited from using genetic informa-
tion when making decisions regarding employee compensation and
promotion. In this manner, employers would be required to treat
genetic information in the same manner as other immutable and
genetically determined characteristics, such as age, race, or sex, when
making employment decisions.149 Under this approach, employees
will receive maximum protection against potential discrimination in
employment on the basis of their unique genetic make-up.
H. Enforcement
In order to encourage compliance with the provisions of the
legislation, the WSGPA must provide for a private right of action
against anyone violating its provisions.50 Thus, a person would be
able to bring an action against a physician who disclosed personal
genetic information without consent, or against an employer who
denied a promotion based on an employee's genetic test results.
Without the "teeth" of civil remedies behind it, health care providers,
insurance companies, and employers will have little incentive to comply
with the WSGPA.
In sum, adequate protection of genetic information requires
comprehensive regulation-from sample collection through disclosure
of information and ultimate destruction of samples. The Washington
legislature should incorporate the suggestions presented in this section
and develop a Genetic Privacy Act for the state, in order to protect the
genetic privacy of Washington citizens.
I. Consistency with the State Constitution
The Washington State Constitution provides extensive protection
of personal privacy through Article 1, section 7, which states:
No person shall be disturbed in his private affairs, or his home
invaded, without authority of law."'
In the context of medical records, the Washington Supreme Court
recognizes that the right to avoid disclosure of personal matters to the
149. Washington law prohibits discrimination in employment on the basis of "race, creed,
color, national origin, families with children, sex, marital status, age, or the presence of any
sensory, mental, or physical disability." WASH. REV. CODE § 49.60.010 (1996).
150. See ANNAS ET AL., supra note 10, at 42. See also WASH. REV. CODE § 70.12.170
(1996) (providing for civil remedies against health care providers who violate the Washington
State Health Care Information Access and Disclosure Act).
151. WASH. CONST. art. 1, § 7.
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government is the essence of privacy, and is a right that is constitution-
ally protected.112  It follows that genetic information, as part of a
medical record, is subject to the privacy protections offered by the state
constitution. In other words, Washington citizens have a right to
avoid disclosure of genetic information to the government. In this
regard, the proposed WSGPA is consistent with the right to privacy
available under the state constitution.
However, under the Washington constitution, the right to medical
records privacy is not absolute. 153 The disclosure of intimate infor-
mation, including medical records, to state government agencies is
allowed if there is some legitimate state interest necessitating disclo-
sure, and if the disclosure is carefully tailored and no greater than
necessary."' Consequently, the WSGPA would not totally prevent
nonconsensual disclosure of genetic information to government
agencies. However, any such disclosure to a state agency must serve
some legitimate state interest, and must only be as extensive as
reasonably necessary to further the state's interest.
While Washington case law has defined constitutional protections
against government access to intimate information, those same
protections do not appear to apply to nongovernmental access to
intimate information. 5  Therefore, a party harmed because an
insurance company or some other nongovernmental entity disclosed
genetic information without consent would probably not be able to rely
on the state constitution as a basis for a remedy. The WSGPA would
essentially extend the privacy protections of the state constitution, by
providing a private cause of action to parties harmed by nonconsensual
disclosure of genetic information.
VII. CONCLUSION
This Comment concludes that genetic information must be given
special status as health information that is part of a medical record in
order to protect individual privacy and autonomy with respect to
unique, personal, and predictive genetic information. As Maria
152. See Peninsula Counseling Center v. Rahm, 105 Wash. 2d at 940-41, 719 P.2d 931-32.
In this regard, the state constitution provides a greater right to privacy than is found under the
federal constitution, where the same interest is not explicitly recognized. Id.
153. See id. at 933-34, 719 P.2d at 928-29 (1986).
154. See id.; see also WASH. REV. CODE § 70.02.050(2) (1996) (authorizing disclosure of
health care information to government health authorities under specific circumstances).
155. See Doe v, Puget Sound Blood Center, 117 Wash. 2d 772, 783, 819 P.2d 370, 376
(1991) (declining to address the issue of whether a constitutional right to privacy can be invoked
without state action).
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Silverwood learned, failure to provide this special status gives rise to
concerns about personal privacy and autonomy and creates a significant
risk of harm, including discrimination in insurance and employment.
The current law in Washington does not adequately protect the
privacy of personal genetic information, and regulation to protect
genetic information does not appear to be forthcoming from the federal
government. Consequently, Washington should enact its own Genetic
Privacy Act in order to protect genetic privacy and to prevent genetic
discrimination within the state.
